Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 07, 2025 02:30 ET | Source: eleva GmbH

Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers

First-in-human administration of CPV-104 marks a major step in drug development for the company’s lead compound (Factor H) and in bringing a new medication to patients Freiburg im Breisgau, Germany,...
May 13, 2025 02:30 ET | Source: eleva GmbH

Eleva Appoints Donato Spota as Chief Financial Officer

Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, appointed Mr. Donato Spota...